BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 772524)

  • 1. [Heterogeneity of immunoreactive calcitonin in the plasma of patients with bone marrow cancer].
    Moukhtar MS; Jullienne A; Taboulet J; Calmettes C; Raulais D; Milhaud G
    Pathol Biol (Paris); 1975 Dec; 23(10):809-14. PubMed ID: 772524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
    Rude RK; Matsumoto S; Singer FR
    Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
    Woloszczuk W; Kovarik J
    Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.
    Sizemore GW; Hpeath H; Larson JM
    J Clin Invest; 1975 May; 55(5):1111-8. PubMed ID: 47335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
    Roof BS; Weinstein R; Vujic I; Burdash NM
    Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical heterogeneity of calcitonin in plasma.
    Deftos LJ; Roos BA; Bronzert D; Parthemore JG
    J Clin Endocrinol Metab; 1975 Mar; 40(3):409-12. PubMed ID: 163843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The circulating forms of human calcitonin].
    Heynen G; Franchimont P
    Pathol Biol (Paris); 1975 Dec; 23(10):815-9. PubMed ID: 772525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma.
    Birnbaum RS; Muszynski M; Roos BA
    Cancer Res; 1980 Nov; 40(11):4192-6. PubMed ID: 6110476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.
    Goltzman D; Tischler AS
    J Clin Invest; 1978 Feb; 61(2):449-58. PubMed ID: 621283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of immunoreactive calcitonin in sera and tissues of lung cancer patients.
    Luster W; Gropp C; Sostmann H; Kalbfleisch H; Havemann K
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1275-83. PubMed ID: 6299749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
    Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
    Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
    Becker KL; Snider RH; Silva OL; Moore CF
    Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
    Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
    Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin in breast and lung cancer.
    Hillyard CJ; Coombes RC; Greenberg PB; Galante LS; MacIntyre I
    Clin Endocrinol (Oxf); 1976 Jan; 5(1):1-8. PubMed ID: 942890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of non-commercial methods for estimation of immunoreactive serum calcitonin in clinical practice (comparison of two methods).
    Bednár J; Neradilová M; Soutorová M; Bílek R; Nĕmec J; Pechová M; Havelka J
    Czech Med; 1991; 14(4):205-12. PubMed ID: 1842705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of plasma and urinary immunoreactive calcitonin in patients with medullary carcinoma of the thyroid.
    Morimoto S; Okada Y; Onishi T; Takai S; Miyauchi A; Lee S; Nishioka Y; Kumahara Y
    Endocrinol Jpn; 1981 Oct; 28(5):583-94. PubMed ID: 7344949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of calcitonin in seminal plasma of infertile men.
    Badr O; Imam A; Monieb H; Khalifa A; al Ahmady O; Abdallah MA
    Andrologia; 1989; 21(5):416-22. PubMed ID: 2817444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoreactive serum calcitonin in breast cancer].
    Fereberger W; Leb G; Passath A; Samonigg H; Beaufort F
    MMW Munch Med Wochenschr; 1982 May; 124(19):471-2. PubMed ID: 6810110
    [No Abstract]   [Full Text] [Related]  

  • 19. Secretion of calcitonin in hypocalcemic states in man.
    Deftos LJ; Powell D; Parthemore JG; Potts JT
    J Clin Invest; 1973 Dec; 52(12):3109-14. PubMed ID: 4750444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin-producing pancreatic somatostatinoma.
    Galmiche JP; Chayvialle JA; Dubois PM; David L; Descos F; Paulin C; Ducastelle T; Colin R; Geffroy Y
    Gastroenterology; 1980 Jun; 78(6):1577-83. PubMed ID: 6102950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.